2022
Sentinel Lymph Node Biopsy Positivity in Patients With Acral Lentiginous and Other Subtypes of Cutaneous Melanoma
Cheraghlou S, Ugwu N, Girardi M. Sentinel Lymph Node Biopsy Positivity in Patients With Acral Lentiginous and Other Subtypes of Cutaneous Melanoma. JAMA Dermatology 2022, 158: 51-58. PMID: 34878492, PMCID: PMC8655663, DOI: 10.1001/jamadermatol.2021.4812.Peer-Reviewed Original ResearchConceptsAcral lentiginous melanomaNational Cancer DatabaseClinical stage IBSLN positivityStage IBSentinel lymphCutaneous melanomaPositivity rateMalignant melanomaHigh riskSentinel lymph node statusAJCC Cancer Staging ManualClinical stage IRetrospective cohort studySignificant prognostic factorsLymph node statusCancer Staging ManualMultivariable logistic regressionHigher positivity rateAJCC clinical stageCohort studySLN statusPrognostic factorsSuch patientsStaging Manual
2019
Comparison of Survival After Mohs Micrographic Surgery vs Wide Margin Excision for Early-Stage Invasive Melanoma
Cheraghlou S, Christensen SR, Agogo GO, Girardi M. Comparison of Survival After Mohs Micrographic Surgery vs Wide Margin Excision for Early-Stage Invasive Melanoma. JAMA Dermatology 2019, 155: 1252-1259. PMID: 31553403, PMCID: PMC6764120, DOI: 10.1001/jamadermatol.2019.2890.Peer-Reviewed Original ResearchWide margin excisionMohs micrographic surgeryNational Cancer DatabaseOverall survivalInvasive melanomaStage IMargin excisionCancer DatabaseMicrographic surgeryCox proportional hazards regression survival analysisCox proportional hazards regression analysisCancer (AJCC) Cancer Staging ManualUse of MMSPropensity score-matched analysisProportional hazards regression analysisCancer-accredited facilitiesRetrospective cohort studyAmerican Joint CommitteeCancer Staging ManualHazards regression analysisCommon malignant neoplasmTreatment of melanomaRegression survival analysisComparison of survivalEligible patientsPathologic staging changes in oral cavity squamous cell carcinoma: Stage migration and implications for adjuvant treatment
Lee NCJ, Eskander A, Park HS, Mehra S, Burtness BA, Husain Z. Pathologic staging changes in oral cavity squamous cell carcinoma: Stage migration and implications for adjuvant treatment. Cancer 2019, 125: 2975-2983. PMID: 31090934, DOI: 10.1002/cncr.32161.Peer-Reviewed Original ResearchConceptsOral cavity squamous cell carcinomaPathologic extranodal extensionDepth of invasionAJCC Cancer Staging ManualCancer Staging ManualSquamous cell carcinomaOverall survivalPT3N0 patientsStage migrationStaging ManualCell carcinomaStaging systemAJCC-8 staging systemPathologic tumor classificationNational Cancer DatabaseRisk of deathNew staging systemPStage IVBUpstaged tumorsAdjuvant treatmentDefinitive surgeryExtranodal extensionPostoperative radiotherapyPT classificationPT1 tumors
2018
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.
Flaig T, Spiess P, Agarwal N, Bangs R, Boorjian S, Buyyounouski M, Downs T, Efstathiou J, Friedlander T, Greenberg R, Guru K, Hahn N, Herr H, Hoimes C, Inman B, Jimbo M, Kader A, Lele S, Meeks J, Michalski J, Montgomery J, Pagliaro L, Pal S, Patterson A, Petrylak D, Plimack E, Pohar K, Porter M, Preston M, Sexton W, Siefker-Radtke A, Tward J, Wile G, Johnson-Chilla A, Dwyer M, Gurski L. NCCN Guidelines Insights: Bladder Cancer, Version 5.2018. Journal Of The National Comprehensive Cancer Network 2018, 16: 1041-1053. PMID: 30181416, DOI: 10.6004/jnccn.2018.0072.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, IntravesicalAftercareBCG VaccineChemotherapy, AdjuvantCystectomyHumansLymphatic MetastasisMedical OncologyNeoadjuvant TherapyNeoplasm StagingOrgan Sparing TreatmentsPatient SelectionQuality of LifeRadiotherapy, AdjuvantRandomized Controlled Trials as TopicSocieties, MedicalTreatment OutcomeUnited StatesUrinary Bladder NeoplasmsConceptsBladder cancerTreatment of muscle-invasive bladder cancerImmune checkpoint inhibitor therapyMuscle-invasive bladder cancerNCCN Clinical Practice GuidelinesFollow-up of patientsAJCC Cancer Staging ManualCheckpoint inhibitor therapyCancer Staging ManualNCCN Guidelines InsightsClinical practice guidelinesMetastatic diseaseInhibitor therapyStaging ManualTreatment optionsFollow-upCancerBladderPractice guidelinesPatientsNCCNTreatmentAJCCTherapyGuidelines
2017
MP86-17 THE 2017 AMERICAN JOINT COMMITTEE ON CANCER EIGHTH EDITION CANCER STAGING MANUAL: CHANGES IN STAGING GUIDELINES FOR CANCERS OF THE KIDNEY, RENAL PELVIS AND URETER, BLADDER, AND URETHRA
Robins D, Small A, Amin M, Bochner B, Chang S, Choueiri T, Efstathiou J, Gospodarowicz M, Hansel D, Kenney P, Konety B, Landman J, Lee C, Leibovich B, Plimack E, Reuter V, Rini B, Sridhar S, Stadler W, Tickoo S, Vikram R, Zhou M, McKiernan J. MP86-17 THE 2017 AMERICAN JOINT COMMITTEE ON CANCER EIGHTH EDITION CANCER STAGING MANUAL: CHANGES IN STAGING GUIDELINES FOR CANCERS OF THE KIDNEY, RENAL PELVIS AND URETER, BLADDER, AND URETHRA. Journal Of Urology 2017, 197: e1163. DOI: 10.1016/j.juro.2017.02.2700.Peer-Reviewed Original Research
2011
A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Creation and rationale for inclusion of tumor (T) characteristics
Farasat S, Yu S, Neel V, Nehal K, Lardaro T, Mihm M, Byrd D, Balch C, Califano J, Chuang A, Sharfman W, Shah J, Nghiem P, Otley C, Tufaro A, Johnson T, Sober A, Liégeois N. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Creation and rationale for inclusion of tumor (T) characteristics. Journal Of The American Academy Of Dermatology 2011, 64: 1051-1059. PMID: 21255868, PMCID: PMC4659347, DOI: 10.1016/j.jaad.2010.08.033.Peer-Reviewed Original ResearchConceptsAmerican Joint Committee on CancerCutaneous squamous cell carcinomaAmerican Joint Committee on Cancer staging systemSquamous cell carcinomaStaging systemT classificationCell carcinomaStaging ManualAmerican Joint Committee on Cancer Staging ManualAmerican Joint Committee on Cancer Cancer Staging ManualIncidence of cutaneous squamous cell carcinomaMultivariate analysisPurposes of stagingCancer staging systemHigh-risk featuresCancer Staging ManualNonmelanoma skin cancerProspective outcome trialsTumor thicknessTumor characteristicsTumor diameterPerineural invasionAdvanced diseaseSurgical treatmentStaging criteria
2010
Improvements in the Staging of Cutaneous Squamous-Cell Carcinoma in the 7th Edition of the AJCC Cancer Staging Manual
Lardaro T, Shea S, Sharfman W, Liégeois N, Sober A. Improvements in the Staging of Cutaneous Squamous-Cell Carcinoma in the 7th Edition of the AJCC Cancer Staging Manual. Annals Of Surgical Oncology 2010, 17: 1979-1980. PMID: 20490700, DOI: 10.1245/s10434-010-1009-0.Peer-Reviewed Original ResearchAdequate Lymph Node Assessment for Extrahepatic Bile Duct Adenocarcinoma
Ito K, Ito H, Allen P, Gonen M, Klimstra D, D'Angelica M, Fong Y, DeMatteo R, Brennan M, Blumgart L, Jarnagin W. Adequate Lymph Node Assessment for Extrahepatic Bile Duct Adenocarcinoma. Annals Of Surgery 2010, 251: 675-681. PMID: 20224368, DOI: 10.1097/sla.0b013e3181d3d2b2.Peer-Reviewed Original ResearchConceptsExtrahepatic bile duct cancerTotal lymph node countLymph node countAdequate lymph node assessmentDisease-specific survivalBile duct cancerLymph nodesDuct cancerAmerican Joint Committee on Cancer Staging ManualMedian total lymph node countAdequate lymph node samplingMetastasis to regional lymph nodesDistal bile duct cancerNode countCurative intent resectionFactor of poor survivalLymph node assessmentLymph node statusPrognostic factor of poor survivalBile duct adenocarcinomaCancer Staging ManualLog-rank testRegional lymph nodesExtrahepatic bile duct adenocarcinomaLymph node sampling
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply